Fucoidan extracted from Fucus vesiculosus promoted activation of tumor-infiltrating CD8+ T-cells and strongly inhibited growth of melanoma cells when co-administrated with anti-PD-1, particularly when applied before immunotherapy [35]. The gene discussed is CD8A; the disease is melanoma.